Details for New Drug Application (NDA): 019058
✉ Email this page to a colleague
NDA 019058 describes TENORMIN, which is a drug marketed by Astrazeneca and Twi Pharms and is included in two NDAs. It is available from one supplier. Additional details are available on the TENORMIN profile page.
The generic ingredient in TENORMIN is atenolol. There are thirty-four drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the atenolol profile page.
The generic ingredient in TENORMIN is atenolol. There are thirty-four drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the atenolol profile page.
Summary for 019058
| Tradename: | TENORMIN |
| Applicant: | Astrazeneca |
| Ingredient: | atenolol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019058
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Sep 13, 1989 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
